Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Bofill

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Annals of Pharmacotherapy|August 6, 2000
Fluorouracil-induced aphasiaJ S Bofill, M Chaves, J A Moreno
Journal of the National Cancer Institute|September 20, 2001
Irinotecan-induced dysarthriaD V Baz, J S Bofill, J A Nogueira
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2017
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2016
Defining the optimal sequence for the systemic treatment of metastatic breast cancerJ A Mestres, A B iMolins, L C Martínez, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Annals of Pharmacotherapy|August 6, 2000
Fluorouracil-induced aphasiaJ S Bofill, M Chaves, J A Moreno
Journal of the National Cancer Institute|September 20, 2001
Irinotecan-induced dysarthriaD V Baz, J S Bofill, J A Nogueira
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 28, 2017
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 5, 2018
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practiceI Blancas, M Fontanillas, V Conde, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 18, 2016
Defining the optimal sequence for the systemic treatment of metastatic breast cancerJ A Mestres, A B iMolins, L C Martínez, et al.
Pageof 1